Expression of e-cadherin and Ki-67 in cervical cancer: a study in a tertiary care hospital, Dhaka, Bangladesh


  • Rizwana R. Khan Department of Pathology, Dhaka Medical College, Dhaka, Bangladesh
  • Thanadar A. Flora Department of Pathology, Dr. Sirajul Islam Medical College, Dhaka, Bangladesh
  • Urmilata Biswas Department of Pathology, Kumudini Women’s Medical College, Tangail, Bangladesh
  • Jubyda S. Rashid Department of Pathology, Shaheed Suhrawardy Medical College, Dhaka, Bangladesh
  • Shirin G. Zabin Department of Pathology, Dhaka Medical College, Dhaka, Bangladesh



Cervical cancer, Biomarkers, Ki-67, E-cadherin, Hysterectomy, Biopsy


Background: Cervical cancer, ranking as the second most prevalent cancer and a leading cause of female cancer-related deaths in low to middle-income nations, exhibits a notable connection between tumor proliferation (Ki-67) and invasiveness (e-cadherin). Both factors contribute significantly to cervical cancer's aggressiveness. This study aims to establish the clinical-pathological link between e-cadherin and Ki-67 expression in cervical carcinoma, and assess their potential as diagnostic biomarkers.

Methods: This cross-sectional study spanned July 2017 to June 2019 at Sir Salimullah Medical College and Mitford Hospital Dhaka. It encompassed 60 adult female patients histopathologically diagnosed with cervical cancer. All patients underwent e-cadherin, Ki-67 expression assessments, and histopathological diagnosis. Ethical clearance was granted by SSMC Institutional Ethics Committee.

Results: E-cadherin expression presented as follows: strong intensity in 36.7% cases, weak and homogeneous in 35.0%, weak and heterogeneous in 8.3%, negative staining in 15.1%, and negative expression in 5.0%. Ki-67 mean levels varied significantly among different types of cervical cancer (p<0.05). Squamous cell carcinoma was predominant (80.0%), with heightened e-cadherin expression in well-differentiated cases (14 cases). Notably, cases with no e-cadherin expression exhibited Ki-67 mean of 71.0±7.9, while those with strong E-cadherin expression displayed Ki-67 mean of 56.5±8.2 (p<0.05). A significant negative correlation (r=-0.300; p=0.022) emerged between Ki-67 LI (%) and e-cadherin expression.

Conclusions: E-cadherin correlates effectively with clinicopathological features and Ki-67 expression in cervical carcinoma. This underscores its pivotal role in cervical cancer progression.


Stănculescu RV, Brătilă E, Bauşic V, Vlădescu TC, Vasilescu F, Bauşic A, et al. Review of the biotechnologies and tests used for precancerous cervical lesions diagnosis. Rom J Morphol Embryol. 2017;58(1):7-14.

Ancuta E, Ancuta C, Cozma LG, Iordache C, Anghelache-Lupascu I, Anton E, et al. Tumor biomarkers in cervical cancer: focus on Ki-67 proliferation factor and E-cadherin expression. Rom J Morphol Embryol. 2009;50(3):413-8.

De Boer CJ, van Dorst E, van Krieken H, Jansen-van Rhijn CM, Warnaar SO, Fleuren GJ, et al. Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. Am J Pathol. 1999;155(2):505-15.

Yim EK, Park JS. Biomarkers in cervical cancer. Biomarker insights. 2006;1:117727190600100015.

Mehrotra A, Goel MM. Assessment of monoclonal antibody MIB-1 labeling indices in cervical intraepithelial lesions of the uterine cervix in paraffin section. J Obstet Gynecol India. 2008;58(4):327.

Ozawa M, Kemler R. The membrane-proximal region of the E-cadherin cytoplasmic domain prevents dimerization and negatively regulates adhesion activity. J Cell Biol. 1998;142(6):1605-13.

Al-Aynati MM, Radulovich N, Riddell RH, Tsao MS. Epithelial-cadherin and β-catenin expression changes in pancreatic intraepithelial neoplasia. Clin Canc Res. 2004;10(4):1235-40.

Gama A, Schmitt F. Cadherin cell adhesion system in canine mammary cancer: a review. Vet Med Int. 2012;357187.

Cavalcante JR, Sampaio JPA, Maia Filho JTA, Vieira RB, Eleutério J, Júnior L, et al. Progressive loss of E-cadherin immunoexpression during cervical carcinogenesis. Acta Cirurgica Brasileira. 2014;29(10):667-74.

Crasta J, Ravikumar G, Koorse S, Siddharta P, Vallikad E. Expression of adhesion molecule epithelial cadherin and matrix metalloproteinase-9 in squamous neoplasia of the uterine cervix. Southern Afr J Gynaecol Oncol. 2016;8(1):4-8.

Sun H, Liu X, Li M. E-cadherin expression and its clinical significance in cervical cancer. Chinese J Oncol. 2000;22(6):496-8.

Agnihotri P, Akhtar K, Siddiqui SA, Sherwani RK. Cervical Cancer Metastasis: Significance of E-Cadherin and Vimentin. Clinical Research. 2015;1(2):1-5.

Munhoz NG, Rodrigues DA, Takase Y, Pedregosa JF, Rodrigues JO, Miyazaki K, et al. The use of molecular markers (p16, Ki-67 and E-Cadherin) in uterine cervical biopsies. Open Pathol J. 2009;3(1):10-7.

Panjkovic M, Ivkovic-Kapicl T. Ki-67 expression in squamous intraepithelial lesions of the uterine cervix. Arch Oncol. 2006;14(1-2):23-5.

Goel MM, Mehrotra, A. Immunohistochemical expression of MIB-1 and PCNA in precancerous and cancerous lesions of uterine cervix. Indian J Cancer. 2013;50(3):200.

Kuo KT, Chang HC, Hsiao CH, Lin MC. Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion. Br J Ophthalmol. 2006;90(7):894-9.

Anju M, Mati GM. Assessment of monoclonal antibody MIB-1 labeling indices in cervical intraepithelial lesion of the uterine cervix in paraffin section. J Obst Gyn India. 2008;58(4):327-32.

Kruse AJ, Baak JP, de Bruin PC, Jiwa M, Snijders WP, Jan Boodt P, et al. Ki‐67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading. J Pathol. 2001;193(1):48-54.






Original Research Articles